Angioplasty May Be Feasible for Liver Transplantation Candidates With Heart Disease, Cedars-Sinai Medical Center Study

Published: Jun 22, 2011

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).

Back to news